1. "Nursing"
Formats
  1. Journal Article (1702)
  2. Meeting Abstract (1536)
  3. Book Section (121)
  4. Review (103)
  5. Editorial (78)
  6. Conference Paper (26)
  7. Research Letter (17)
  8. Book Whole (15)
  9. Miscellaneous (13)
  10. Correspondence (12)
  11. Guidelines (10)
Groups
  1. Nursing (3633)
  2. Department of Medicine (1470)
  3. Advanced Practice Providers (1108)
  4. Survivorship Research (942)
  5. Solid Tumor Oncology Division (863)
  6. Epidemiology and Biostatistics (622)

More Groups

People
  1. William Rosa (199)
  2. Nessa Coyle (123)
  3. Sergio Giralt (115)
  4. Mark Kris (113)
  5. Howard Scher (100)
  6. Andrew Zelenetz (97)

More People

Years
  1. 2025 (73)
  2. 2024 (204)
  3. 2023 (196)
  4. 2022 (204)
  5. 2021 (171)
  6. 2020 (179)

More Years

Publications
  1. Journal of Clinical Oncology (448)
  2. Oncology Nursing Forum (389)
  3. Blood (207)
  4. Clinical Journal of Oncology Nursing (119)
  5. Biology of Blood and Marrow Transplantation (88)
  6. Clinical Cancer Research (69)

More Publications

Publishers
  1. Oncology Nursing Society (ONS) (533)
  2. American Society of Clinical Oncology (487)
  3. Elsevier Inc. (455)
  4. Lippincott Williams & Wilkins (255)
  5. American Society of Hematology (220)
  6. American Association for Cancer Research (155)

More Publishers

Results (3633)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Distress screening for oncology family caregivers: A mixed-methods feasibility study
    Meeting Abstract

    Shaffer, K. M.; Benvengo, S.; Zaleta, A. K.; Levine, M. R.; Bellantoni, C. E.; Dannaoui, A.; Buzaglo, J.; Applebaum, A.
    Annals of Behavioral Medicine (2019)

    Fulltext@MSK | Save
  • Guillain Barré syndrome heralding the diagnosis of angioimmunoblastic T-cell lymphoma
    Journal Article

    Pathak, P.; Perimbeti, S.; Ames, A.; Moskowitz, A. J.
    Leukemia and Lymphoma (2019)

    Fulltext@MSK | Save
  • Tumor lysis, adverse events, and dose adjustments in 297 venetoclax-treated CLL patients in routine clinical practice
    Journal Article

    Roeker, L. E.; Fox, C. P.; Eyre, T. A.; Brander, D. M.; Allan, J. N.; Schuster, S. J.; Nabhan, C.; Hill, B. T.; Shah, N. N.; Lansigan, F.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Trajectories of fasting blood glucose in autologous hematopoietic cell transplantation
    Journal Article

    Hammer, M. J.; Paul, S. M.; Steinberg, A.; Eckardt, P.; Barton-Burke, M.; Miaskowski, C.
    Cancer Nursing (2019)

    Fulltext@MSK | Save
  • Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition
    Journal Article

    Pianko, M. J.; Devlin, S. M.; Littmann, E. R.; Chansakul, A.; Mastey, D.; Salcedo, M.; Fontana, E.; Ling, L.; Tavitian, E.; Slingerland, J. B.; more...
    Blood Advances (2019)

    Fulltext@MSK | Save
  • Hypertension (HTN) in patients (pts) treated with ibrutinib (IBR) for chronic lymphocytic leukemia (CLL)
    Meeting Abstract

    Sarraf Yazdy, M.; Roeker, L.; Gashonia, L.; Goodfriend, J.; Narkhede, M.; Rhodes, J.; Kennard, K.; Morse, H.; Dorsey, C.; Battiato, K.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Phase I clinical trial of CD19‐targeted 19‐28z/4‐1BBL "armored" CAR T cells in patients with relapsed or refractory NHL and CLL including Richter transformation
    Meeting Abstract

    Batlevi, C. L.; Palomba, M. L.; Park, J.; Mead, E.; Santomasso, B.; Riviere, I.; Wang, X.; Senechal, B.; Furman, R.; Yang, J.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • Phase I/II study of umbralisib (TGR‐1202) in combination with ublituximab (TG‐1101) and pembrolizumab in patients with REL/REF CLL and Richter's transformation
    Meeting Abstract

    Mato, A. R.; Svoboda, J.; Luning Prak, E. T.; Schuster, S. J.; Tsao, P. Y.; Dorsey, C.; Sarmasti, L. M.; Becker, P. S.; Brander, D. M.; Nasta, S.; more...
    Hematological Oncology (2019)

    Fulltext@MSK | Save
  • A phase II trial of sorafenib and dacarbazine for leiomyosarcoma, synovial sarcoma, and malignant peripheral nerve sheath tumors
    Journal Article

    D'Adamo, D. R.; Dickson, M. A.; Keohan, M. L.; Carvajal, R. D.; Hensley, M. L.; Hirst, C. M.; Ezeoke, M. O.; Ahn, L.; Qin, L. X.; Antonescu, C. R.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Giving voice to patient values throughout cancer: A novel nurse-led intervention
    Journal Article

    Epstein, A. S.; Desai, A. V.; Bernal, C.; Romano, D.; Wan, P. J.; Okpako, M.; Anderson, K.; Chow, K.; Kramer, D.; Calderon, C.; more...
    Journal of Pain and Symptom Management (2019)

    Fulltext@MSK | Save